MELISSA LOBUE: Open Payments
NPI 1205350766 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,659 in 211 payments from 25 companies in 2025. Trend: 2023 $5,049 · 2024 $4,348 · 2025 $4,659
Food & beverage: $4,659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $747 |
| Amgen Inc. | 45 | $652 |
| Janssen Biotech, Inc. | 18 | $354 |
| UCB, Inc. | 18 | $327 |
| GlaxoSmithKline, LLC. | 10 | $321 |
| E.R. Squibb & Sons, L.L.C. | 7 | $297 |
| Mallinckrodt Hospital Products Inc. | 11 | $281 |
| Novartis Pharmaceuticals Corporation | 9 | $246 |
| ANI Pharmaceuticals, Inc. | 8 | $237 |
| Lilly USA, LLC | 12 | $205 |
Products named: RINVOQ, TREMFYA, SKYRIZI, BENLYSTA, Bimzelx, ORENCIA, ACTHAR, PURIFIED CORTROPHIN GEL.
Industry payments across SC — which companies pay providers there.
